Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HPI-Guided Therapy vs Continuous Norepinephrine for C-Section Hypotension
NCT05970770Phase 4Unknown
- Sponsor
- Policlinico Gemelli
- Start
- Sep 2023
- Primary completion
- Sep 2025
01
Overview
Phase 4, randomised trial (2 arms), sponsored by Policlinico Gemelli. Primary endpoint: Fetal Base Excess. Status: unknown.
Beyond the preview
Go deeper on NCT05970770.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05970770.